Ardsley Advisory Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

Ardsley Advisory Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$41K	–	163
2018 Q3	$41K	Buy	+10,000	New	+$45.4K	0.01%	149
2016 Q1	–	Sell	-65,000	Closed	-$293K	–	187
2015 Q4	$293K	Sell	65,000 -105,000	-62%	-$443K	0.04%	108
2015 Q3	$539K	Buy	170,000 +25,000	+17%	+$75.9K	0.13%	84
2015 Q2	$439K	Buy	145,000 +25,000	+21%	+$70.3K	0.06%	117
2015 Q1	$354K	Buy	120,000 +70,000	+140%	+$229K	0.05%	143
2014 Q4	$222K	Buy	50,000 +35,000	+233%	+$167K	0.04%	160
2014 Q3	$77K	Sell	15,000 -10,000	-40%	-$53.4K	0.01%	177
2014 Q2	$131K	Sell	25,000 -100,000	-80%	-$432K	0.02%	233
2014 Q1	$520K	Buy	125,000 +40,000	+47%	+$137K	0.08%	133
2013 Q4	$248K	Buy	+85,000	New	+$211K	0.03%	135

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ardsley Advisory Partners's ENZ Position: Q4 2018 in Review

Ardsley Advisory Partners sold out of Enzo Biochem, Inc. (ENZ) in Q4 2018, closing a stake of 10,000 shares — an estimated $41K sold.

Ardsley Advisory Partners first reported a position in ENZ in Q4 2013 and held it in 10 quarters. The position peaked at $539K in Q3 2015. 91 funds tracked by Wall St. Rank hold ENZ as of Q4 2018.

Ardsley Advisory Partners reported no remaining Enzo Biochem, Inc. position as of Q4 2018 after selling out during the quarter.
Ardsley Advisory Partners sold 10,000 Enzo Biochem, Inc. shares in Q4 2018, an estimated $41K.
Ardsley Advisory Partners first reported a position in Enzo Biochem, Inc. in Q4 2013 and held it in 10 quarters.
Ardsley Advisory Partners's Enzo Biochem, Inc. position peaked at $539K in Q3 2015.
91 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2018.

Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.